TRIC-TB
Description
Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments
Accession number
ef760136-5f11-11eb-917b-acde48001122
Project acronym
TRIC-TB
Project website
Start date
2019-05-01
End date
2023-04-30
Funding
IMI2 - Call 16 (Grant number 853800)
Types
